YENOM NOTICIAS

Qué está moviendo el mercado.

Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.

WST
Limpiar

Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.

finance.yahoo.comPOSITIVO

Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets

Smith+Nephew SNN recently announced the European commercial launch of its CARTIHEAL AGILI-C Cartilage Repair Implant, expanding the availability of its cartilage repair technology across key markets in the region. The launch marks another…

finance.yahoo.comPOSITIVO

Here's Why You Should Retain WAT Stock in Your Portfolio for Now

Waters WAT is well-poised for growth in the coming quarters, driven by sustained demand for analytical sciences, an extended instrument replacement cycle, BD integration and synergies, product innovation and growing opportunities in biosep…

finance.yahoo.comPOSITIVO

West to Host Third-Quarter 2026 Conference Call

EXTON, Pa., Oct. 8, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter financial results befor…

finance.yahoo.comPOSITIVO

West Pharmaceutical Services (WST) Stock Could Be 17% Overvalued As Cash Flow Falls Short

West Pharmaceutical Services has seen its share price climb sharply in recent periods, and that kind of run naturally raises a question for anyone looking at the stock today: Are the cash flows the business can generate over time enough to…

finance.yahoo.comPOSITIVO

Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now

Fresenius Medical Care AG & Co. FMS entered 2026 with improving profitability, accelerating execution of its transformation strategy and growing momentum in HighVolumeHDF and value-based care. However, persistent treatment volume weakness,…

finance.yahoo.comPOSITIVO

BDX Expands U.S. Manufacturing With $19B Healthcare Investment

Becton, Dickinson and Company BDX, popularly known as BD, recently announced a landmark partnership with the U.S. Government to expand domestic manufacturing of essential medical consumables and strengthen healthcare supply-chain resilienc…

finance.yahoo.comPOSITIVO

Reasons to Hold HealthEquity Stock in Your Portfolio for Now

HealthEquity, Inc. HQY has been gaining from its business model and strategy. The optimism, led by a solid second-quarter fiscal 2027 performance and strength in Health Savings Accounts (HSAs), is expected to contribute further. However, d…

finance.yahoo.comPOSITIVO

Veeva's DQS Scales Data Automation Across 1,000+ Clinical Studies

Veeva Systems VEEV continues to strengthen its position in the life sciences software market as its Veeva DQS (Data Quality System) platform expands its reach across clinical trials. The company said that the solution has now supported dat…

finance.yahoo.comPOSITIVO

Here's Why You Should Add Merit Medical Stock to Your Portfolio Now

Merit Medical Systems, Inc. MMSI is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by solid product performance, global expansion and strategic M&A, is expected to contribute furt…

finance.yahoo.comPOSITIVO

GE HealthCare Expands U.S. PET Radiopharma Reach With SOFIE Deal

GE HealthCare Technologies Inc. GEHC recently announced a definitive agreement to acquire SOFIE Biosciences, a U.S.-based contract manufacturing organization (CMO) specializing in PET radiopharmaceuticals, for $945 million in cash. The acq…

finance.yahoo.comPOSITIVO

Reasons to Retain Cardinal Health Stock in Your Portfolio for Now

Cardinal Health CAH enters fiscal 2027 with strong momentum across pharmaceutical distribution, specialty solutions and growth businesses. Specialty pharmaceuticals, cell-and-gene therapy capabilities and expanding non-core operations shou…

finance.yahoo.comPOSITIVO

Reasons to Retain Doximity Stock in Your Portfolio for Now

Doximity DOCS is entering a pivotal phase as it accelerates investments in artificial intelligence (AI) to expand beyond its core physician engagement platform. While robust physician adoption, growing enterprise AI deployments and excepti…

finance.yahoo.comPOSITIVO

Veeva's OpenData to Help Servier Build a Global AI Data Foundation

Veeva Systems VEEV recently announced that Servier has selected Veeva OpenData to standardize customer reference data across more than 80 countries. The move strengthens Veeva's position as a key provider of data solutions for global life…

finance.yahoo.comPOSITIVO

Inspire Medical Gains New CPT Codes for Hypoglossal Nerve Stimulation

Inspire Medical Systems, Inc. INSP recently announced that the American Medical Association's (AMA) CPT Editorial Panel approved new Category I CPT codes for procedures involving a single lead and implantable pulse generator (IPG), includi…

finance.yahoo.comPOSITIVO

West to Highlight Industry Leadership in Packaging and Containment at CPHI Worldwide

EXTON, Pa., Oct. 5, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its participation in CPHI Worldwide in Milan, Italy, where…

finance.yahoo.comPOSITIVO

1 Cash-Producing Stock on Our Buy List and 2 Facing Challenges

1 Cash-Producing Stock on Our Buy List and 2 Facing Challenges A company that generates cash isn't automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luckily for you, we bu…

finance.yahoo.comPOSITIVO

Drug Development Inputs & Services Stocks Q2 Highlights: West Pharmaceutical Services (NYSE:WST)

Drug Development Inputs & Services Stocks Q2 Highlights: West Pharmaceutical Services (NYSE:WST) Quarterly earnings results are a good time to check in on a company's progress, especially compared to its peers in the same sector. Today we…

finance.yahoo.comPOSITIVO

Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care

Smith+Nephew SNN recently launched the new EVOS PELVIC Plating System, expanding its EVOS trauma platform into pelvic and acetabular fracture management. The launch strengthens the company's orthopedic trauma portfolio by adding a dedicate…

finance.yahoo.comPOSITIVO

Here's Why You Should Retain Integer Holdings Stock in Your Portfolio

Integer Holdings Corporation ITGR has been gaining from its research and product development activities. The optimism, led by a mixed second-quarter 2026 performance and its strength in core product franchises, is expected to contribute fu…

finance.yahoo.comPOSITIVO

Here's Why You Should Retain BDX Stock in Your Portfolio for Now

Becton, Dickinson and Company BDX is benefiting from its focused transformation into a pure-play MedTech company, supported by strong execution of its BD 2025 strategy. The company's continued emphasis on innovation, strategic partnerships…

finance.yahoo.comPOSITIVO

Veeva Unveils AI Study Builder Agent to Speed Clinical Trial Setup

Veeva Systems VEEV recently introduced Veeva Study Builder Agent, a new AI-powered solution designed to accelerate clinical study configuration within its Clinical Data platform. The launch reinforces Veeva's push to embed AI across its li…

finance.yahoo.comPOSITIVO

Here's Why You Should Retain Glaukos Stock in Your Portfolio for Now

Glaukos Corporation's GKOS growth prospects are supported by the continued expansion of interventional glaucoma, growing clinical and commercial synergies between iDose TR and iStent infinite, and the potential for long-term operating leve…

finance.yahoo.comPOSITIVO

Veeva Unveils Falcon Router to Streamline Biopharma Case Routing

Veeva Systems VEEV recently expanded its AI strategy with the launch of Falcon Router, a new agentic solution designed to help biopharma companies streamline the intake and routing of safety, quality and medical cases across reporting chan…

finance.yahoo.comPOSITIVO

Here's Why You Should Retain IRTC Stock in Your Portfolio for Now

iRhythm Holdings IRTC is well-positioned for solid growth over the next few quarters, courtesy of its strong second-quarter 2026 results and structural market expansion. The company's investments in AI, large-scale ECG data and clinical va…

finance.yahoo.comPOSITIVO

West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says

West Pharmaceutical Services (WST) could see earnings per share upside of at least 10% to current Wa PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…

finance.yahoo.comPOSITIVO

1 S&P 500 Stock with Exciting Potential and 2 We Ignore

1 S&P 500 Stock with Exciting Potential and 2 We Ignore While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or…

finance.yahoo.comPOSITIVO

Reasons to Hold Hinge Health Stock in Your Portfolio for Now

Hinge Health HNGE is well-positioned for sustained growth, driven by robust revenue growth, expanding opportunities in Migraine and gastrointestinal (GI) care and a scalable AI-powered MSK platform. The raised 2026 outlook, broader enterpr…

finance.yahoo.comPOSITIVO

1 Surging Stock with Solid Fundamentals and 2 That Underwhelm

1 Surging Stock with Solid Fundamentals and 2 That Underwhelm The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends,…

finance.yahoo.comPOSITIVO

Layoffs, Cyber Disruptions, Annex 1 Upgrades Might Change The Case For Investing In West (WST)

West Pharmaceutical Services recently announced it will phase out a product line at its Scottsdale facility by the end of September, resulting in 98 layoffs and related manufacturing work being shifted to other Becton, Dickinson and Co. lo…

finance.yahoo.comPOSITIVO

What Is Drawing Attention To West Pharmaceutical Services (WST)?

West Pharmaceutical Services (WST) is juggling mixed signals after recent updates on its business outlook. Investors now have to balance long-term growth drivers with fresh headwinds from a cyber incident, cost inflation, and a Scottsdale…

finance.yahoo.comPOSITIVO

Avantor Broadens RIM Single-Use Bioprocessing Reach in APAC

Avantor, Inc. AVTR recently expanded the availability of RIM single-use bioprocessing portfolio across the Asia Pacific (APAC) region, strengthening its presence in a key biopharma manufacturing market. The move aims to provide regional cu…

finance.yahoo.comPOSITIVO

Reasons to Add West Pharmaceutical Stock to Your Portfolio Now

West Pharmaceutical Services, Inc. WST is well positioned for growth, backed by strong demand for HVPs, expanding biologics exposure and regulatory-driven Annex 1 conversions. However, tariff impacts and weak West Vantage results, which we…

finance.yahoo.comPOSITIVO

Beta Bionics Stock Surges on FDA Clearance for Mint Patch Pump

Beta Bionics, Inc. BBNX recently secured FDA clearance for its Mint patch pump, marking a key milestone in expanding its automated insulin delivery portfolio. The company also unveiled its next-generation 3D Intelligence insulin dosing alg…

finance.yahoo.comPOSITIVO

Here's Why You Should Hold Solventum Stock in Your Portfolio for Now

Solventum Corporation SOLV is well-poised for growth in the coming quarters, driven by strong demand across its business segments, supported by continued investment in innovation, R&D and digital capabilities. The optimism, led by a solid…

seekingalpha.comPOSITIVO

Stock futures point higher as Fed delivers rate hike

[The New York Stock Exchange on the Wall street sign] Dmitry Vinogradov Stock index futures were higher on Thursday, a day after Wall Street ended lower following the Federal Reserve's interest rate hike. Dow futures (INDU [https://seeking…

finance.yahoo.comPOSITIVO

Here's Why You Should Add Avantor Stock to Your Portfolio for Now

Avantor, Inc. AVTR is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism led by strong second-quarter 2026 results and cost transformation progress also looks promising. However, weakness…